Interesting I wonder when the FDA will get off it’s fat ass and figure this thing out.
Interesting I wonder when the FDA will get off it’s fat ass and figure this thing out.
= = = = = = = = = = = = =
Fairly obvious...WHY waste time and effort with an affordable drug, already approved, has had some good reviews for this ‘problem’ and in stock at a ‘cheap price’.
NO sense going that way when Billions can be made testing a NEW drug which can make Trillions.
FOLLOW THE MONEY...
It is shameful.
The FDA, NIH and “Big Pharma” all provide huge funding to large university medical centers to run clinical trials/double-blind studies. These are necessary before new drugs (or drug treatments) can receive FDA authorization/approval. While I am not averse to “Big Pharma” in general, the current relationship between them and the various federal regulatory agencies is unhealthy and does not serve the taxpayer well.
Bottom Line: It is much more profitable for a university medical center to develop clinical trials for a new and relatively unknown drug than to approve a well known, safe, generic drug for a different (”off label”) use.
If hydroxychloraquin helps people, the economy, or the President of the United States then the FDA WILL HELP——NEVER!